[go: up one dir, main page]

MA52957A - Procédés de fabrication de compositions d'acides aminés - Google Patents

Procédés de fabrication de compositions d'acides aminés

Info

Publication number
MA52957A
MA52957A MA052957A MA52957A MA52957A MA 52957 A MA52957 A MA 52957A MA 052957 A MA052957 A MA 052957A MA 52957 A MA52957 A MA 52957A MA 52957 A MA52957 A MA 52957A
Authority
MA
Morocco
Prior art keywords
processes
manufacturing
amino acid
acid compositions
compositions
Prior art date
Application number
MA052957A
Other languages
English (en)
Inventor
Thomas Hanlon
Denise K Kwok
Daniel Rothenberg
Andrew M Wood
Ralph Yamamoto
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MA52957A publication Critical patent/MA52957A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MA052957A 2018-06-20 2019-06-19 Procédés de fabrication de compositions d'acides aminés MA52957A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862687725P 2018-06-20 2018-06-20

Publications (1)

Publication Number Publication Date
MA52957A true MA52957A (fr) 2021-04-28

Family

ID=67226342

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052957A MA52957A (fr) 2018-06-20 2019-06-19 Procédés de fabrication de compositions d'acides aminés

Country Status (17)

Country Link
US (1) US11679089B2 (fr)
EP (1) EP3810168A1 (fr)
JP (1) JP2021529735A (fr)
KR (1) KR20210023846A (fr)
CN (1) CN112823018A (fr)
AR (1) AR115581A1 (fr)
AU (1) AU2019288371A1 (fr)
BR (1) BR112020025831A2 (fr)
CA (1) CA3099762A1 (fr)
CL (1) CL2020003277A1 (fr)
IL (1) IL279328A (fr)
JO (1) JOP20200323A1 (fr)
MA (1) MA52957A (fr)
MX (1) MX2020013732A (fr)
SG (1) SG11202011611XA (fr)
TW (1) TW202015668A (fr)
WO (1) WO2019246201A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN110678172A (zh) 2017-04-28 2020-01-10 胺细拉健康公司 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CA3099762A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Procedes de fabrication de compositions d'acides amines
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
US11737999B2 (en) 2021-07-26 2023-08-29 Axcella Health Inc. Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
WO1994014458A1 (fr) 1992-12-23 1994-07-07 Abbott Laboratories Aliments a usage medical destines au soutien nutritionnel de nouveaux-nes/de bebes souffrant de maladies metaboliques
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (fr) 1997-07-14 1999-01-20 N.V. Nutricia Composition dietique contenant de la methionine
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
JP4108605B2 (ja) * 2001-11-13 2008-06-25 協和醗酵工業株式会社 アミノ酸含有口腔内速崩壊錠及びその製造方法
ATE334998T1 (de) * 2003-04-07 2006-08-15 Novetide Ltd Verfahren zur herstellung cyclischer peptide
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
CA2552440A1 (fr) 2003-12-30 2005-07-21 Dr. Reddy's Laboratories Ltd. Composition pharmaceutique
US20060073254A1 (en) 2004-10-04 2006-04-06 Steve Catani No-carb tabletop sweeteners substitute
WO2006062238A1 (fr) 2004-12-07 2006-06-15 Ajinomoto Co., Inc. Poudre fine d’acide amine et suspension la contenant
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
WO2011043647A1 (fr) * 2009-10-09 2011-04-14 N.V. Nutricia Composition d'acide aminé avec aptitude à la dispersion améliorée
JP2012136492A (ja) 2010-12-25 2012-07-19 Shiga Prefecture Seiyaku Kk 服用感を改善された漢方内服液剤
WO2015002527A1 (fr) * 2013-07-05 2015-01-08 N.V. Nutricia Composition d'acides aminés destinée à être utilisée dans le traitement d'un trouble envahissant du développement
WO2015015149A1 (fr) 2013-07-31 2015-02-05 Leeds Metropolitan University Complément alimentaire
CN107223020A (zh) 2013-09-25 2017-09-29 胺细拉健康公司 用于预防和治疗糖尿病和肥胖症的组合物和制剂及其产生和用于葡萄糖和卡路里控制的方法
US20180125926A1 (en) 2013-09-25 2018-05-10 Axcella Health Inc. Compositions and Formulations and Methods of Production and Use Thereof
FR3032883B1 (fr) * 2015-02-24 2017-03-17 International Nutrition Res Company Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
JO3543B1 (ar) * 2015-09-28 2020-07-05 Applied Pharma Res تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم
ES2878580T3 (es) * 2016-02-04 2021-11-19 Czap Res And Development Llc Vehículos de complejos de inclusión de ciclodextrina estratificados y de liberación controlada
PL238958B1 (pl) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
US20180015122A1 (en) * 2016-07-14 2018-01-18 Companion Supplements, LLC Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20190147A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
JP2018154598A (ja) 2017-03-21 2018-10-04 株式会社明治 アミノ酸含有顆粒およびその製造方法
CN110678172A (zh) 2017-04-28 2020-01-10 胺细拉健康公司 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CA3072092A1 (fr) 2017-08-14 2019-02-21 Axcella Health Inc. Acides amines a chaine ramifiee pour le traitement d'une lesion neuronale
US20190388377A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders
EP3810122A1 (fr) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions et procédés pour la réduction ou le traitement de la résistance à l'insuline et d'états métaboliques
MA52960A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour la réduction ou le traitement de la fibrose
CA3101058A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions pour therapie et soin contenant des acides amines ayant un gout amer
CA3099762A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Procedes de fabrication de compositions d'acides amines
MA52961A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour la réduction ou le traitement d'une inflammation
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo

Also Published As

Publication number Publication date
CL2020003277A1 (es) 2021-07-09
EP3810168A1 (fr) 2021-04-28
CA3099762A1 (fr) 2019-12-26
KR20210023846A (ko) 2021-03-04
US20190388374A1 (en) 2019-12-26
MX2020013732A (es) 2021-02-26
AR115581A1 (es) 2021-02-03
US11679089B2 (en) 2023-06-20
JOP20200323A1 (ar) 2020-12-14
JP2021529735A (ja) 2021-11-04
AU2019288371A1 (en) 2020-12-03
SG11202011611XA (en) 2021-01-28
BR112020025831A2 (pt) 2021-03-23
TW202015668A (zh) 2020-05-01
CN112823018A (zh) 2021-05-18
WO2019246201A1 (fr) 2019-12-26
IL279328A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
MA52957A (fr) Procédés de fabrication de compositions d'acides aminés
MA49045A (fr) Compositions et procédés destinés à la distribution régulée d'acide
MA51792A (fr) Procédés de fabrication de lymphocytes t
EP3612023A4 (fr) Procédés de production d'animaux génétiquement modifiés
EP3622080C0 (fr) Procédés améliorés pour la production d'isobutène à partir d'acide 3-méthylcrotonique
IL286592B (en) Amino acid compounds for the treatment of liver disease
EP3386550A4 (fr) Procédés et compositions pour la fabrication et l'utilisation d'acides nucléiques de guidage
MA42055A (fr) Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci
EP3751001C0 (fr) Procédé de fabrication d'ergothionéine
MA45290A (fr) Procédés et compositions d'agents biologiquement actifs
EP4013853A4 (fr) Procédés améliorés de fabrication de compositions organoïdes
EP3598537A4 (fr) Procédé de fabrication de mélange d'électrode et mélange d'électrode
EP3924159C0 (fr) Procédé de fabrication d'ancres ventouses
EP3852631A4 (fr) Procédé d'imagerie
EP3455895A4 (fr) Compositions et procédés pour la fabrication d'électrode
IL282114A (en) Processes for preparing functionalized cyclooctenes
MA52417A (fr) Procédés de modification de composition corporelle
EP3316970A4 (fr) Procédés impliquant la régulation à la baisse de l'apobec3b
EP3940821A4 (fr) Procédé de fabrication d'anode
EP3830280A4 (fr) Procédé de production de nouveaux échafaudages diterpéniques
EP3859332A4 (fr) Procédé de dosage d'hémoglobine glyquée (%)
EP3980013A4 (fr) Procédés de préparation de composés aminopyrimidine
MA55282A (fr) Procédés de fabrication pour la production de compositions d'anticorps anti-tnf
MA49791A (fr) Procédés de fabrication de compositions d'allergènes mixtes
MA53391A (fr) Compositions pour l'agriculture et procédés associés